1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Industry Rumors

This is the place to find out about the latest "unofficial" news in the industry. Remember, these are only rumors!


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    570
  2. Anonymous
    Replies:
    51
    Views:
    22,728
  3. anonymous
    Replies:
    0
    Views:
    897
  4. anonymous
    Replies:
    0
    Views:
    1,844
  5. anonymous
    Replies:
    3
    Views:
    789
  6. anonymous
    Replies:
    0
    Views:
    847
  7. Anonymous
    Replies:
    13
    Views:
    6,990
  8. anonymous
    Replies:
    1
    Views:
    3,933
  9. anonymous
    Replies:
    0
    Views:
    990
  10. anonymous
    Replies:
    0
    Views:
    1,909
  11. anonymous
    Replies:
    7
    Views:
    5,433
  12. anonymous
    Replies:
    0
    Views:
    1,965
  13. anonymous
    Replies:
    0
    Views:
    2,604
  14. Anonymous
    Replies:
    129
    Views:
    47,538
  15. anonymous
    Replies:
    0
    Views:
    1,320
  16. anonymous
    Replies:
    0
    Views:
    1,865
  17. anonymous
    Replies:
    0
    Views:
    1,649
  18. anonymous
    Replies:
    10
    Views:
    3,449
  19. anonymous
    Replies:
    2
    Views:
    3,746
  20. Dazoweslots
    Replies:
    4
    Views:
    7,268

Thread Display Options

Loading...